Background

Dr. Sophie Dessureault earned her medical degree from Dalhousie University in Halifax, Nova Scotia. She completed her general surgery residency at the University of Toronto in Ontario and her surgical oncology fellowship at the H. Lee Moffitt Cancer Center, affiliated with the University of South Florida.

Dr. Dessureault currently practices as a surgical oncologist at the Moffitt Cancer Center. She also serves as Professor of Oncology and Surgery at the University of South Florida Morsani College of Medicine. Some of her special areas of interest include abdominal malignancies, such as malignant peritoneal mesothelioma.

Hyperthemic Intraperitoneal Chemotherapy for the Treatment of Mesothelioma 

Dr. Dessureault performs regional treatment of advanced abdominal malignancies, such as when malignant peritoneal mesothelioma spreads beyond the peritoneal lining of the abdominal cavity. Unlike systemic chemotherapy, hyperthermic intraperitoneal chemotherapy (HIPEC) targets tumors directly, which helps to make it more effective and have less side effects. It is paired with cytoreduction, surgical removal of all visible tumors within the abdominal cavity. Then, HIPEC is delivered, bathing the abdominal cavity in chemotherapy for about 90 minutes to help kill any residual cancer cells.

When facing a diagnosis of an asbestos-related abdominal malignancy such as mesothelioma, it is crucial to find the right treatment right away. With Dr. Sophie Dessureault, you are in good hands. Contact Dr. Dessureault today.